Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical TrialJAMA : the journal of the American Medical Association, 2019-05, Vol.321 (19), p.1880 [Peer Reviewed Journal]EISSN: 1538-3598 ;DOI: 10.1001/jama.2019.5790 ;PMID: 31037289Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Spectral domain optical coherence tomography classification of diabetic macular edema: a new proposal to clinical practiceGraefe's archive for clinical and experimental ophthalmology, 2020-06, Vol.258 (6), p.1165-1172 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;Springer-Verlag GmbH Germany, part of Springer Nature 2020. ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-020-04640-9 ;PMID: 32152718Full text available |
|
3 |
Material Type: Article
|
Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical TrialArchives of ophthalmology (1960), 2021-07, Vol.139 (7), p.701 [Peer Reviewed Journal]Copyright American Medical Association Jul 2021 ;ISSN: 2168-6165 ;EISSN: 2168-6173 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0606 ;PMID: 33784735Full text available |
|
4 |
Material Type: Article
|
Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implantActa ophthalmologica (Oxford, England), 2020-03, Vol.98 (2), p.e217-e223 [Peer Reviewed Journal]2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd ;2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd. ;Copyright © 2020 Acta Ophthalmologica Scandinavica Foundation ;ISSN: 1755-375X ;EISSN: 1755-3768 ;DOI: 10.1111/aos.14230 ;PMID: 31421028Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I DataAmerican journal of ophthalmology, 2016-12, Vol.172, p.72-79 [Peer Reviewed Journal]2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.012 ;PMID: 27644589 ;CODEN: AJOPAAFull text available |
|
6 |
Material Type: Article
|
Choroidal structural analysis in eyes with diabetic retinopathy and diabetic macular edema-A novel OCT based imaging biomarkerPloS one, 2018-12, Vol.13 (12), p.e0207435-e0207435 [Peer Reviewed Journal]COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Gupta et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Gupta et al 2018 Gupta et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0207435 ;PMID: 30533048Full text available |
|
7 |
Material Type: Article
|
Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON studyGraefe's archive for clinical and experimental ophthalmology, 2020-03, Vol.258 (3), p.521-528 [Peer Reviewed Journal]The Author(s) 2019 ;Graefe's Archive for Clinical and Experimental Ophthalmology is a copyright of Springer, (2019). All Rights Reserved. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-019-04592-9 ;PMID: 31894377Full text available |
|
8 |
Material Type: Article
|
Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME studyBritish journal of ophthalmology, 2020-09, Vol.104 (9), p.1209-1215 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2019-315199 ;PMID: 31784500Full text available |
|
9 |
Material Type: Article
|
Pro-permeability Factors in Diabetic Macular Edema; the Diabetic Macular Edema Treated with Ozurdex TrialAmerican journal of ophthalmology, 2016-08, Vol.168, p.13-23 [Peer Reviewed Journal]Elsevier Inc. ;2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 1, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.04.017 ;PMID: 27130369Full text available |
|
10 |
Material Type: Article
|
Functional and anatomical changes in diabetic macular edema after hemodialysis initiation: One-year follow-up multicenter studyScientific reports, 2020-05, Vol.10 (1), p.7788-7788, Article 7788 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-64798-4 ;PMID: 32385333Full text available |
|
11 |
Material Type: Article
|
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trialsThe Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503Full text available |
|
12 |
Material Type: Article
|
Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical TrialArchives of ophthalmology (1960), 2019-04, Vol.137 (4), p.382 [Peer Reviewed Journal]Copyright American Medical Association Apr 2019 ;ISSN: 2168-6165 ;EISSN: 2168-6173 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2018.6786 ;PMID: 30676635Full text available |
|
13 |
Material Type: Article
|
Intravitreal injection of a Rho-kinase inhibitor (fasudil) combined with bevacizumab versus bevacizumab monotherapy for diabetic macular oedema: a pilot randomised clinical trialBritish journal of ophthalmology, 2019-07, Vol.103 (7), p.922-927 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2018-312244 ;PMID: 30150280Full text available |
|
14 |
Material Type: Article
|
Effects of Crocin on Diabetic Maculopathy: A Placebo-Controlled Randomized Clinical TrialAmerican journal of ophthalmology, 2018-06, Vol.190, p.89-98 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 2018 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2018.03.007 ;PMID: 29550187Full text available |
|
15 |
Material Type: Article
|
Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular EdemaAmerican journal of ophthalmology, 2016-04, Vol.164, p.57-68 [Peer Reviewed Journal]Elsevier Inc. ;2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Apr 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2015.12.025 ;PMID: 26802783 ;CODEN: AJOPAAFull text available |
|
16 |
Material Type: Article
|
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year resultsBritish journal of ophthalmology, 2021-02, Vol.105 (2), p.253-257 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-316176 ;PMID: 32303499Full text available |
|
17 |
Material Type: Article
|
Visual/anatomical outcome of diabetic macular edema patients lost to follow-up for more than 1 yearScientific reports, 2021-09, Vol.11 (1), p.18353-18353, Article 18353 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-97644-2 ;PMID: 34526548Full text available |
|
18 |
Material Type: Article
|
Flare levels after intravitreal injection of brolucizumab for diabetic macular edemaGraefe's archive for clinical and experimental ophthalmology, 2024-06, Vol.262 (6), p.1745-1753 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-024-06374-4 ;PMID: 38217767Digital Resources/Online E-Resources |
|
19 |
Material Type: Article
|
Optical coherence tomography angiography macular biomarkers of peripheral retinal ischemia in diabetic macular edema: secondary endpoints from the clinical study “FOVEA”Graefe's archive for clinical and experimental ophthalmology, 2024-06, Vol.262 (6), p.1777-1783 [Peer Reviewed Journal]The Author(s) 2024 ;2024. The Author(s). ;ISSN: 0721-832X ;EISSN: 1435-702X ;DOI: 10.1007/s00417-024-06372-6 ;PMID: 38244084Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countriesBritish journal of ophthalmology, 2019-08, Vol.103 (8), p.1072-1077 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2018-312284 ;PMID: 30242062Full text available |